M.J. Bertran

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 384 citations · Full text

The burden of chronic disorders on hospital admissions prompts the need for new modalities of care: A cross-sectional analysis in a tertiary hospital

C Hernández, Margarida Jansà, M.T. Sánchez Vidal et al. · QJM · 2009 · 75 citations

Multidimensional analysis of treatment adherence in patients with multiple chronic conditions. A cross-sectional study in a tertiary hospital

Margarida Jansà, C Hernández, Mercè Vidal et al. · Patient Education and Counseling · 2010 · 62 citations

Patient Adherence, Family Medicine, Chronic Disease Management +11

Immunogenicity and reactogenicity of the adult tetanus–diphtheria vaccine. How many doses are necessary?

José M. Bayas, Anna Vilella, M.J. Bertran et al. · Epidemiology and Infection · 2001 · 54 citations · Full text

Dtp Vaccine, Immunodeficiencies, Td Vaccine +19

How do we measure gender discrimination? Proposing a construct of gender discrimination through a systematic scoping review

Laura de la Torre‐Pérez, Alba Oliver-Parra, Xavier Torres et al. · International Journal for Equity in Health · 2022 · 36 citations · Full text